Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

SALATAZ POWDER FOR SOLUTION FOR INJECTION/INFUSION 4.5G/VIAL

Approval Number

SIN15299P

Drug Name

SALATAZ POWDER FOR SOLUTION FOR INJECTION/INFUSION 4.5G/VIAL

Product Name

SALATAZ POWDER FOR SOLUTION FOR INJECTION/INFUSION 4.5G/VIAL

Approval Date

July 14, 2017

Registrant

PAN-MALAYAN PHARMACEUTICALS PTE LTD

Licence Holder

PAN-MALAYAN PHARMACEUTICALS PTE LTD

Regulatory Information

Registrant

PAN-MALAYAN PHARMACEUTICALS PTE LTD

Licence Holder

PAN-MALAYAN PHARMACEUTICALS PTE LTD

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

INJECTION, POWDER, FOR SOLUTION

Route of Administration

INTRAVENOUS

Medical Information

ATC Code

J01CR05

ATC Item Name

piperacillin and beta-lactamase inhibitor

Manufacturer Information

Pharmaceutical Manufacturer

PAN-MALAYAN PHARMACEUTICALS PTE LTD

Manufacturers

Shandong Anxin Pharmaceutical Co., Ltd. (Intermediate Bulk Drug Product Manufacturer)

Laboratorio Reig Jofré, S.A.

Active Ingredients

Ingredient Name

Tazobactam sodium 536.6mg eqv Tazobactam

Strength

500mg

Drug MonographTazobactam

Ingredient Name

Piperacillin Sodium 4.17g eqv Piperacillin

Strength

4g

Drug MonographPiperacillin

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy